According to The European Crohn’s and Colitis Organization (ECCO), patients under immunosuppressive/immunomodulatory treatment are not in a significant increased risk of catching COVID-19. As the risk of severe infections is slightly higher in patients under immunosuppression therapies, it is expected that the same might occur in SARS-CoV-2 infections. But data from immunosuppressed patients and SARS-CoV-2 ...

#Siste magasin

BestPractice Nordic

Nr. 1 • mars 2020
1. Årgang
  • Arterosklerotisk sykdom
  • Kreftscreening
  • Depresjon